Anteris Technologies fields excellent 30-day haemodynamic results for DurAVR™ THV in US early feasibility study

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has released 30-day data described as "excellent" from its US early feasibility study (EFS) for the DurAVR™...

Related Keywords

Wayne Paterson ,Chris Meduri ,Michael Reardon ,Anteris Technologies Ltd ,Effective Orifice Area ,Pressure Gradient ,Velocity Index ,Balloon Expandable ,